Table 1.

Participant characteristics.

	Melbourne study		Oslo study
Cohort	CD	SR-GS	SR-GS
Number	26	18	49
Females, n (%)	17 (65%)	14 (78%)	43 (88%)
Median age in y (range)	51 (20–66)	53 (27–70)	46 (21–72)
Medically diagnosed CD, n (%)	26 (100%)	0	0
GFD duration in mo, median (range)	66 (1–360)	78 (0.5–180)	35 (5–180)
GFD > 1 y, n (%)	20 (77%)	15 (83%)	34 (69%)
Elevated baseline TG2-IgA, n (%)	4 (15%)	0	0
Elevated baseline DGP-IgG, n (%)	6 (23%)	0	7 (14%)
HLA-DQ2.5 positive, n (%)	25 (96%)	6 (33%)	18 (37%)
HLA-DQ2.5, 2.2, 8 & 7 negative, n (%)	0	2 (11%)	22 (45%)

CD: coeliac disease; GFD: gluten-free diet; SR-GS: self-reported gluten sensitivity.